OptiCept Technologies Interim Report Q3 2025
OptiCept Technologies AB (publ) is bringing forward the interim report for the third quarter of 2025 to today, 21 November, instead of the previously communicated date of 27 November 2025. The reason for bringing the date forward is that the work on the report has been completed earlier than expected.
OptiCept Technologies AB (publ), today published its Interim Report for Q3 2025 (July – September 2025).
SIGNIFICANT EVENTS Q3 2025
- OptiCept signs agreement with world-leading producer of alcoholic beverages
- New Order from Spain – OptiCept Continues to Gain Ground in the Olive Oil Industry
- OptiCept receives third order from Spanish customer – continues expansion in the olive oil industry
- OptiCept receives order worth approximately SEK 3.6 million from leading olive oil producer in Spain
- Breakthrough in a fast-growing market: OptiCept secures SEK 2 million order in avocado oil extraction
- New Patent Strengthens OptiCept Technologies’ Market Position
- OptiCept Technologies AB changes Certified Adviser to Tapper Partners AB
- OptiCept Expands Production Capacity of CEPT® Systems
- OptiCept launches system for larger volumes
- OptiCept reduces its production costs by 40%
- OptiCept Receives New Order from Juice Producer in Costa Rica
| FINANCIAL OVERVIEW | ||||
| KSEK (unless otherwise stated)* | Q3 (jul-sep) | Q1-Q3 (jan-sep) | ||
| 2025 | 2024 | 2025 | 2024 | |
| Net Sales** | 19 837 | 3 883 | 26 307 | 12 289 |
| Total revenue** | 24 435 | 6 302 | 35 879 | 24 788 |
| Operating Income | -2 523 | -12 471 | -36 145 | -38 591 |
| Result for the period | -4 121 | -13 150 | -39 182 | -38 168 |
| Inbound Orders*** | 9 258 | 2 100 | 27 191 | 11 296 |
| Open orders*** | 8 878 | 50 960 | 8 878 | 50 960 |
| Reported EBITDA | 54 | -9 944 | -28 388 | -27 691 |
| Net result for the period | 391 289 | 380 669 | 391 289 | 380 669 |
| Cash & cash equivalents | 3 624 | 4 559 | 3 624 | 4 559 |
| Equity | 330 811 | 340 399 | 330 811 | 340 399 |
| Equity ratio (%) | 85% | 89% | 85% | 89% |
| Average number of shares in the period | 63 019 272 | 45 982 664 | 62 837 675 | 45 982 664 |
| Number of shares at the end of the period | 64 844 683 | 51 496 408 | 64 844 683 | 51 496 408 |
| Earnings per share before and after dilution (SEK) | -0,07 | -0,29 | -0,62 | -0,83 |
| Cash flow from operating activities | -9 734 | -11 041 | -29 708 | -32 802 |
| Total Cash flow | -8 418 | 537 | -18 053 | -9 556 |
| For information regarding alternative performance measures, please refer to Note 5. | ||||
| * Rounding may occur so that in some cases the amounts do not add up | ||||
| ** For information regarding net revenue, please refer to Note 2. | ||||
| ***Open orders excluding FPS, please refer to Note 1 | ||||
SIGNIFICANT EVENTS AFTER PERIOD END
- OptiCept Technologies AB announces Nomination Committee ahead of the 2026 Annual General Meeting
- OptiCept is building a regional sales organization
”The results we are now reporting, together with the preparations we have made, enable us to now
present our goal of achieving a positive EBITDA result for the full year 2026”, comments Thomas Lundqvist, CEO, OptiCept Technologies.
The report is available on the company's website: https://investor.opticept.se/finansiell-information/finansiella-rapporter/